LipidIQ

Terms of Service

Effective: April 16, 2026

⚠️ LipidIQ is a clinical decision-support tool intended exclusively for use by licensed healthcare professionals. It is not intended for patient self-management or lay use.

1. Acceptance of Terms

By downloading, installing, or using LipidIQ ("the App"), you agree to be bound by these Terms of Service. If you do not agree, do not use the App.

2. Intended Use

LipidIQ is designed as a reference and decision-support tool for licensed healthcare professionals. Content is based on the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia and landmark clinical trial data.

3. Disclaimers

4. Subscription and Billing

Certain features require a paid subscription ("LipidIQ AI — Monthly") billed at $2.99/month via the Apple App Store. A 7-day free trial is offered to new subscribers.

5. Intellectual Property

All content, algorithms, and design elements within LipidIQ are the property of the developer. Guideline summaries are derived from publicly available ACC/AHA publications; original guideline text remains the property of its respective copyright holders.

6. Limitation of Liability

To the fullest extent permitted by law, the developer shall not be liable for any direct, indirect, incidental, or consequential damages arising from use of or inability to use the App, including any clinical outcomes resulting from reliance on App content.

7. Changes to These Terms

We reserve the right to update these Terms at any time. Continued use of the App following notice of changes constitutes acceptance of the revised Terms.

8. Contact

📧 texastesla01@gmail.com